Skip to content

North Carolina unified in attracting new ARPA-H headquarters to the state

Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for Health headquarters to North Carolina.

NCBIO Roadmap to Diversity Event

“Our workforces are more dynamic. They're more empowered, they're more enlightened, and they want answers not just from the standpoint of their functional skills and capabilities in our business performance. But also what is it that our company stands for?” -- Keynote speaker Celeste Warren, VP, Merck Global Diversity and Inclusion Center

IP rights are at the heart of innovation and investment

In June, the World Trade Organization agreed to waive IP protections for COVID-19 vaccines, a decision supported by the Biden administration. The WTO is now considering expanding the waiver to include COVID-19 therapeutics and diagnostics.

Bio Business Solutions

NCBIO Members Save Big with BIO Business Solutions

BIO Business Solutions offers NCBIO members the opportunity to pool their purchasing power with other life science companies nationwide to command significant discounts for frequently used products and services.

Bio Business Solutions

NCBIO, the North Carolina Biosciences Organization

NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. Founded in 1994, NCBIO works to help North Carolina’s life sciences community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life through effective advocacy and policy.

Member Benefits

A variety of discount programs are available to members.

Collaboration and statewide support make North Carolina a thriving hub of urgently needed innovation in rare disease.

February 28, 2023

The rarest day on the calendar is the one that does not even occur in every year: February 29. In 2008, this was designated as Rare Disease Day and since then, the last day of February has been an opportunity to draw attention to, honor and support people living with these conditions.

Read More

Where things stand with the TRIPS waiver

November 2, 2022

The World Trade Organization is considering continuing to waive certain intellectual property rights on COVID-19 diagnostics and therapeutics, following a recent decision to do the same for vaccines.

Read More

Expanding COVID IP waiver would harm small, medium enterprises, CSBA says

October 28, 2022

Every member of the Council of State Bioscience Associations signed a letter to President Joe Biden expressing serious concerns with the proposed expansion of IP protections for COVID technology.

Read More

Part D drug price “negotiation” comes at cost of jobs, investment, cures 

August 11, 2022

Congress passed the Inflation Reduction Act on Aug. 12. Included in the law is a provision that gives Medicare Part D the ability to “negotiate” the price of medicines for the first time. Negotiate is in quotation marks because lawmakers are being ironic; no one can legitimately call the new price-setting policy a negotiation.

Read More

Medical Device Forum panel discusses regulatory, supply chain challenges

May 24, 2023

“Navigating Regulatory and Supply Chain Challenges Today and Tomorrow” was the topic of the May 16 NCBIO Medical Device Luncheon and Forum held at the N.C Biotechnology Center.

The discussion was moderated by Eric Hill, senior director, scientific and technical services for Boston Analytical. The event was sponsored by Clancy & Theys Construction Company, Hughes Pittman & Gupton, Mercury Business Services, UniClean Cleanroom Services and YourBio Health.

To start off, the panelists gave an overview of what was currently happening and most relevant to them in their working environment.

Read More

Panelists offer advice on funding options for emerging companies 

March 30, 2023

Panelists at the NCBIO Emerging Companies Luncheon and Forum held Wednesday, March 22, at the NC Biotechnology Center offering insight into the way their organizations choose investments, when to seek SBIR funding, engaging with a funding agency for the first time and more.

The forum was sponsored by Clancy & Theys Construction Company, JBK Associates International, Nikon and SAS.

The panel was moderated by Kseniya Simpson, Ph.D., associate, Hatteras Venture Partners.

Read More

BMF meeting explores $25 million Build Back Better grant projects 

March 23, 2023

At the March 15 meeting the NCBIO Biomanufacturers Forum, attendees received updates on the $25 million Build Back Better Regional Challenge grant awarded in the fall. In September, a statewide coalition of public and private partner organizations and institutions led by NC Biotech and including NCBIO received the award from the U.S. Economic Development Administration’s Build Back Better Regional Challenge. The grant will support a number of life sciences workforce initiatives collectively called Accelerate NC.

Read More

Photo Gallery: 2023 Legislative Reception

March 2, 2023

Approximately 300 NCBIO member representatives and North Carolina law makers came together Wednesday, March 1, at the NCBIO Legislative Reception held at the NC Museum of History in Raleigh.

Read More

Sustaining Members

BIO logo 2023
Novo Nordisk logo
Pfizer logo

Supporting Members